Market Cap

Leap Therapeutics, Inc. Market Capitalization:

$64.0 Million

USD as of Jan. 1, 2026

business Leap Therapeutics, Inc. Company Profile

Leap Therapeutics, Inc. Main Stock Listing

NASDAQ: LPTX

Market Capitalization History of Leap Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Leap Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $64.0 M -22.29%
Jan. 1, 2025 $82.4 M -21.59%
Jan. 1, 2024 $105.1 M 112.79%
Jan. 1, 2023 $49.4 M -73.97%
Jan. 1, 2022 $189.7 M -16.74%
Jan. 1, 2021 $227.8 M 21.99%
Jan. 1, 2020 $186.8 M -2.05%
Jan. 1, 2019 $190.7 M -70.81%
Jan. 1, 2018 $653.2 M 3.99%
Jan. 1, 2017 $628.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Leap Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Leap Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: LPTX

Stock: FSX: 5MC1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.